Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals (ARMP) EBITDA (2016 - 2018)

Historic EBITDA for Armata Pharmaceuticals (ARMP) over the last 6 years, with Q4 2018 value amounting to -$1.1 million.

  • Armata Pharmaceuticals' EBITDA rose 5344.61% to -$1.1 million in Q4 2018 from the same period last year, while for Dec 2018 it was -$9.4 million, marking a year-over-year increase of 4183.59%. This contributed to the annual value of -$42.4 million for FY2024, which is 378.09% down from last year.
  • Per Armata Pharmaceuticals' latest filing, its EBITDA stood at -$1.1 million for Q4 2018, which was up 5344.61% from -$2.8 million recorded in Q3 2018.
  • Armata Pharmaceuticals' EBITDA's 5-year high stood at $19.3 million during Q3 2014, with a 5-year trough of -$12.0 million in Q1 2014.
  • For the 5-year period, Armata Pharmaceuticals' EBITDA averaged around -$1.9 million, with its median value being -$2.8 million (2018).
  • Examining YoY changes over the last 5 years, Armata Pharmaceuticals' EBITDA showed a top increase of 22158.83% in 2014 and a maximum decrease of 59474.6% in 2014.
  • Quarter analysis of 5 years shows Armata Pharmaceuticals' EBITDA stood at -$2.6 million in 2014, then fell by 13.21% to -$2.9 million in 2015, then plummeted by 303.54% to -$11.9 million in 2016, then surged by 80.07% to -$2.4 million in 2017, then soared by 53.45% to -$1.1 million in 2018.
  • Its last three reported values are -$1.1 million in Q4 2018, -$2.8 million for Q3 2018, and -$3.2 million during Q2 2018.